Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Drug use investigation of Jzoloft.

Trial Profile

Drug use investigation of Jzoloft.

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Sep 2012

At a glance

  • Drugs Sertraline (Primary)
  • Indications Anxiety disorders; Depressive disorders
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 11 Oct 2011 Actual trial end date (Sep 2011) added as reported by ClinicalTrials.gov (Parent trial: NCT00605865).
    • 11 Oct 2011 Actual trial end date (Sep 2011) added as reported by ClinicalTrials.gov (Parent trial: NCT00605865).
    • 11 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov (Parent trial: NCT00605865).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top